Key terms
About CSBR
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CSBR news
Mar 13
8:42am ET
Craig-Hallum downgrades Champions Oncology to Hold amid challenging environment
Mar 13
7:13am ET
Champions Oncology downgraded to Hold from Buy at Craig-Hallum
Mar 08
8:46am ET
Craig-Hallum Gives a Buy Rating to Champions Oncology (CSBR)
Mar 07
9:09am ET
Champions Oncology’s U.S. laboratory receives CAP accreditation
Jan 22
1:21pm ET
Analysts’ Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)
No recent press releases are available for CSBR
CSBR Financials
Key terms
Ad Feedback
CSBR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CSBR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range